Publications
Specialty
Search
Advances in Inflammatory Bowel Disease Network, Gastroenterology
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along with those for influenza, COVID-19, and pneumonia.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/11/2024
HeartFlow Plaque Analysis will be covered by four of seven Medicare Administrative Contractors (MAC) beginning November 24, 2024.
Pharmacy Learning Network
10/11/2024
In this installment of Talking Therapeutics, we explore a first-of-its-kind trial evaluating the potential of SGLT2 inhibitors to prevent chemotherapy-related cardiotoxicity.
First Report Managed Care
10/11/2024
Progression-free survival was significantly longer with amivantamab–lazertinib compared with osimertinib as first-line treatment of untreated EGFR (epidermal growth factor receptor)-mutated advanced non-small-cell lung cancer (NSCLC), according to a study published online ahead of print in the New England Journal of Medicine.
Psych Congress Network
10/11/2024
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic review published in Health Affairs.
Oncology
10/11/2024
According to results presented at ASCO 2024 from the SYMPATICO study population in patients
Oncology
10/11/2024
True or False: According to results from a pooled analysis of 5 clinical trials of acala
Veterans Health Today
10/11/2024
The VA expands tele-emergency care nationwide to improve access to world-class care for veterans.
Veterans Health Today
10/11/2024
The US Department of Veterans Affairs is evaluating the relationship between PFAS exposure during military service and kidney cancer among veterans to potentially provide presumptive benefits for affected individuals.
First Report Managed Care
10/11/2024
A recent study highlights the significant impact of family tumor history on disease-free survival in patients with non-small cell lung cancer (NSCLC), suggesting that familial cancer backgrounds could be critical in tailoring treatment strategies. This research appeared in Scientific Reports.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/11/2024
A new study in rats shows that lactate, a substance found in the muscles, initiates a cascade of actions in the muscles that helps blood vessels relax. Researchers sought to understand how skeletal muscle tissue around the blood vessels could influence how the vessels behave.
First Report Managed Care
10/11/2024
Health plans today face mounting pressure to enhance member engagement while improving health outcomes and control rising costs. As health care inflation continues to outpace general inflation across the United States, health plans are increasingly turning to artificial intelligence (AI) to transform their operations and better serve their members. By leveraging AI-powered solutions, payers can streamline processes, gain actionable insights, and ultimately drive financial, quality, and health performance improvements.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/11/2024
The nanotherapy selectively targets a specific immune cell type that moves into and is a part of the plaque. These treated cells “eat” away parts of the plaque core, removing it from the artery wall and decreasing levels of blood vessel inflammation.
Journal of Clinical Pathways
10/10/2024
Join us as a guest expert discusses the evolving role of clinical pathways in guiding treatment decisions for non-small cell lung cancer in the era of precision medicine and targeted therapies, emphasizing the importance of patient-focused care and continuous adaptation to changing treatment landscapes.
Oncology
10/10/2024
The FDA has approved inavolisib, with palbociclib and fulvestrant for patients with endocrine-resistant, PIK3CA-mutated HR-positive, HER2-negative locally advanced or metastatic breast cancer.
EP Lab Digest
10/10/2024
Abbott Press Release
Oncology
10/10/2024
Koosha Paydary, MD, Rush MD Anderson Cancer Center, discusses the course of treatment he would take for a patient with early-stage non-small cell lung cancer.
Oncology, Journal of Clinical Pathways
10/10/2024
Mariana Gouveia, MD, gives an overview of the use of antibody-drug conjugates for the treatment of patients with endometrial cancer.
Rheumatology & Arthritis, Autoimmune
10/10/2024
Task force produces guidelines focusing on critical elements to help enhance diagnosis and patient care in axial spondyloarthritis.
Pharmacy Learning Network
10/10/2024
In late September 2024, Oak Street Health, a subsidiary of CVS Health since 2023, agreed to pay $60 million to resolve allegations of an illegal Medicare Advantage patient recruitment scheme. The whistleblower who reported the illegal activity will receive $9.9.